2018. Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy. Brazilian Journal of Pharmaceutical Sciences. 54, 4 (Dec. 2018), e17349. DOI:https://doi.org/10.1590/s2175-97902018000417349.